ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2025
Science and technical priorities for private sector action to address biodiversity loss.
Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluating the predictive capacity of coral reef resilience assessments.Scientific reports · 2026Article
- How should we bend the curve of biodiversity loss to build a just and sustainable future?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Target 15 of the Kunming-Montreal Global Biodiversity Framework recognizes the importance of the private sector monitoring, assessing and disclosing biodiversity-related risks, dependencies and impacts. Many businesses and financial institutions are progressing with science-based assessments, targets and disclosures and integrating into strategy, risk management and capital allocation decisions. Developments will continue in response to investor expectations, emerging corporate sustainability reporting regulations in Europe, China and elsewhere and evolving global sustainability reporting standards. Voluntary action is also being encouraged by the disclosure recommendations of the Taskforce on Nature-related Financial Disclosures and the target-setting methods of the Science Based Targets Network. Based on experience supporting the private sector in practice, we identify four critical science and technical advances needed to enable business action at scale and to redirect finance globally to halt and reverse biodiversity loss. First, consensus on indicators and metrics for measuring changes in the state of nature and provision of ecosystem services. Second, access to global, regularly updated, location-specific and consistent nature data. Third, standardized and consistent accounting systems that structure data, support risk management and create accountability at corporate, ecosystem and national levels. Fourth, integrated risk assessment approaches to help corporates, financial institutions, central banks and supervisors to assess nature-related risks.This article is part of the discussion meeting issue 'Bending the curve towards nature recovery: building on Georgina Mace's legacy for a biodiverse future'.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.